Skip to main content
OpenTrials
Completed

NCT Number: NCT05367323

Pain Pressure Threshold Values Versus the Biomechanical-Viscoelastic Findings of L4-5 Supraspinous Ligament in Women Who Underwent Cesarean Delivery With Spinal Anaesthesia

Cesarean delivery is a major obstetric surgery that aims to save the lives of mothers and their neonates from complications that may be related to high-risk pregnancy and difficult delivery (Teguete et al., 2012). According to the updated Egyptian demographic and health survey, the rate of cesarean delivery in Egypt has increased until it reached about 52 % of all deliveries (Abdel-Tawab et al., 2018).

Neuraxial anesthesia, especially spinal anaesthesia has been and continues to be the gold standard anesthesia for cesarean section (Mhyre and Sultan., 2019).

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–35 year

Sex eligibility

Female

Study type

Observational

Primary location

Faculty of physical therapy, South Valley University

Qina, Qena Governorate, 83523, Egypt

About this study

Low back pain (LBP) after neuraxial anaesthesia is a typical mild intensity pain. It is thought to be caused by needle trauma and local anaesthetic myotoxicity. Post-dural puncture backache (PDPB), which is defined as a persistent pain around the puncture site without radicular pain, is a common consequence following spinal anaesthesia (Benzon et al., 2016). Back pain following anaesthesia may be attributed to ligament, fascia, or bone injuries with localized bleeding; rigidity of the spine; anaesthesia-induced relaxation of the paraspinal muscles; flattening of the typical lumbar convexity, and stretching and straining of the lumbosacral ligaments and joint capsules (Benzon et al., 2016).

Pressure algometry is an objective well-known and well-validated method which induces acute experimental pain for determining the Pain Pressure Threshold (PPT) in various parts of the body (Pelfort et al., 2015). The PPT is a quantitative sensory value for tissue sensitivity that is defined as the smallest amount of pressure that causes pain (Ylinen., 2007).

The MyotonPRO is a portable valid device for measuring the biomechanical properties such as stiffness and the viscoelasticity of the superficial myofascial tissue objectively (Nguyen et al., 2022). Stiffness, stress relaxation time and creep are biomechanical and viscoelastic properties of lower lumbar myofascia that can be measured using the MyotonPRO device either in healthy adults or low back pain patients (Ilahi et al., 2020). Also, the MyotonPRO can tell the difference between a trigger point and a non-trigger point in terms of viscoelastic qualities such as stress relaxation time or creeping through objective assessment (Roch et al., 2020).

Stiffness is defined as a biomechanical property that represents the resistance to deformation which is directly related to the clinical measurement of muscle tone felt during palpation (Nordin andFrankel., 2012). Both stress relaxation time and creep are viscoelastic properties of the myofascia. Stress relaxation time means the time for a muscle to return to its original shape from deformation after the removal of the causative external load. However, Creep is defined as the gradual lengthening of a muscle and connective tissues over time when put under persistent tensile stress (Myoton., 2013).

In this study we will investigate if the midline spinal anaesthesia for cesarean delivery will be associated with decreased L4-5 interspinous pain pressure threshold - lower PPT yields higher pain - after cesarean delivery or not, and we will compare these findings of L4-5 interspinous pain pressure threshold and the biomechanical properties (stiffness, relaxation time and creeping) of L4-5 supraspinous ligament. Due to the lack of previous objective studies and to fill the gap in this point, this study will be considered the first conducted study to answer our research question.

The null hypothesis indicates that spinal anaesthesia for cesarean delivery has neither a relative risk for decreased L4-5 interspinous pain pressure threshold nor L4-5 supraspinous ligament biomechanical changes.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All women in the epidural and spinal anesthetic groups gave birth through a cesarean delivery.
  • All women either primiparous or multiparous have not had anesthesia (epidural, spinal ) for at least one year prior to the last obstetric anesthesia.
  • Their ages ranged from 18 to 35 years.
  • All participants had a body mass index (BMI), of not more than 30, and a waist to hip ratio of not more than 1.
  • Participants were assessed between the 6th week to the 12th week postnatal.
  • All participants were able to continue all assessment procedures.
  • They were medically stable.

Exclusion criteria

  • Women who delivered through vaginal delivery.
  • Women who delivered through cesarean delivery, but the used anesthetic technique was the paramedian approach of spinal anesthesia.
  • Women with urinary tract infections and diastasis recti.
  • Women who were below 18 years old or above 35 years old.
  • Women who had (BMI) above 30 or waist to hip ratio above 1.
  • Women who did not continue all assessment procedures.
  • Women who had any non-myofascial low back dysfunctions as women who were diagnosed with lumbar disc prolapse or spondylolisthesis.

Treatment and study plan

Pressure algometry (Baseline 2.2-Pound Dolorimeter) and Myoton PRO device (MyotonPRO; Myoton AS, Tallinn, Estonia)

Device

Both instruments are used for the assessment of the L4-5 interspinous space pain pressure threshold and the biomechanical-viscoelastic properties of L4-5 supraspinous ligament respectively

Other names: Myoton PRO device (MyotonPRO; Myoton AS, Tallinn, Estonia)

Primary outcomes

  1. L4-5 Supraspinous Ligament Pain pressure threshold in Pounds

    Time frame: Assessment will be done 6-12 weeks after the use of anaesthesia during Cesarean section

    The PPT is a quantitative sensory value for tissue sensitivity that is defined as the smallest amount of pressure that causes pain

Secondary outcomes

  1. L4-5 supraspinous ligament Stiffness in Newton/meter

    Time frame: Assessment will be done 6-12 weeks after the use of anaesthesia during Cesarean section

    The MyotonPRO device measures Stiffness which is defined as a biomechanical property that represent the resistance to deformation which is directly related to the clinical measurement of muscle tone felt during palpation

  2. L4-5 supraspinous ligament Stress Relaxation Time in milliseconds

    Time frame: Assessment will be done 6-12 weeks after the use of anaesthesia during Cesarean section

    The MyotonPRO device measures Stress relaxation time which means the time for a muscle to return to its original shape from deformation after removal of the causative external load

  3. L4-5 supraspinous ligament Creep in Deborah number

    Time frame: Assessment will be done 6-12 weeks after the use of anaesthesia during Cesarean section

    The MyotonPRO device measures Creep that is defined as the gradual lengthening of a muscle and connective tissues over time when put under a persistent tensile stress

Sponsors and collaborators

Lead sponsor

South Valley University

Other

Registry information

Official study title

Is Pain Pressure Threshold Consistent With the Biomechanical-Viscoelastic Changes for L4-5 Supraspinous Ligament in Women Undergoing Midline Spinal Anaesthesia for Cesarean Delivery

Important dates

Study start
2021
Primary completion
2022
Study completion
2022
First posted
May 10, 2022
Registry last updated
Oct 10, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.